• First NMR Analyser Designed Specifically for the Clinical Laboratory 

Mass Spectrometry & Spectroscopy

First NMR Analyser Designed Specifically for the Clinical Laboratory 

Nov 16 2012

Agilent Technologies Inc have announced that it has entered into an exclusive supply agreement with LipoScience Inc to provide nuclear magnetic resonance (NMR) components for LipoScience’s Vantera Clinical Analyser. The analyser is the first fully-automated NMR diagnostic platform designed specifically for the clinical laboratory and cleared by the US Food and Drug Administration.

The Vantera Clinical Analyser, which recently received 510(k) clearance from the FDA, combines proprietary signal-processing algorithms and NMR spectroscopic detection to identify and quantify concentrations of lipoproteins and, potentially, small-molecule metabolites.

“We are extraordinarily pleased to join forces with LipoScience to provide key components for this leading-edge diagnostic platform,” said Nick Roelofs, President of Agilent’s Life Sciences Group.

“LipoScience is pioneering a new field of personalised diagnostics based on NMR technology. Broadening access to our proprietary diagnostic tests is central to our vision of becoming a clinical standard of care. We value Agilent’s NMR expertise and look forward to partnering with them in our efforts to decentralise our NMR clinical analyser to leading clinical laboratories and academic centres of excellence,” added Richard O. Brajer, CEO of LipoScience.

Digital Edition

International Labmate 47.6 - Sept 2022

September 2022

In This Edition Chromatography Articles - Eco-Friendly RP-HPLC Mass Spectrometry & Spectroscopy Articles - Occurrence of PFAS in a variety of fish species from the Baltic Sea and freshw...

View all digital editions


Drug Discovery 2022

Oct 04 2022 London, UK

Dioxin 2022

Oct 09 2022 New Orleans, LA, USA

SPICA 2022

Oct 11 2022 Lisbon, Portugal

WWEM 2022

Oct 12 2022 Telford, UK


Oct 18 2022 Gothenburg, Sweden

View all events